MENU

OKUR

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

OnKure Therapeutics (OKUR) Ownership - Who owns OnKure Therapeutics?

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

184.05M

P/E Ratio

62.48

Total Cash

192.11M

Projected Growth

N/A

Total Debt

409K

Revenue

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

4.76

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

OKUR

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for OKUR

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Details